Walking naturally after spinal cord injury using a brain-spine interface.
Henri Lorach, Andrea Galvez, Valeria Spagnolo...
https://pubmed.ncbi.nlm.nih.gov/37225984/Actively Recruiting
Led by Ecole Polytechnique Fédérale de Lausanne · Updated on 2026-06-08
3
Participants Needed
1
Research Sites
208 weeks
Total Duration
This research aims to evaluate the preliminary safety and effectiveness of using a brain-controlled spinal cord stimulation device to restore voluntary movement in people with chronic stroke who have mobility impairments. The study focuses on establishing a direct connection between the participants motor intentions and spinal cord stimulation to improve or restore control of arm and leg movements and support neurological recovery when combined with rehabilitation. Participants will receive an implantable device called the ARC-BSI Stroke system, which includes a 64-channel electrocorticogram ECoG array placed over the motor cortex and two 16-channel spinal cord stimulation systems implanted over the cervical and lumbar regions. The brain signals decoded by the ECoG control the spinal cord stimulation in real time to assist with training and rehabilitation aimed at recovering voluntary movements. During the study, participants will undergo assessments before implantation and at multiple points after surgery, including 6 months, 1 year, and then yearly up to 5 years. Outcome measures include safety monitoring and evaluations of motor function, walking ability, muscle strength, spasticity, and neurological recovery using standardized tests and gait analyses. Participants are expected to attend all scheduled visits and comply with study procedures over the 5-year period.
CONDITIONS
Brain-controlled Spinal Cord Stimulation in Participants With Chronic Stroke for Lower and Upper Limb Rehabilitation
J
Jocelyne Bloch, MD
H
Henri Lorach, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Ecole Polytechnique Fédérale de Lausanne
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 5 years
Participants receive implantation of a 64 channel electrocorticogram (ECoG) array over the sensory motor cortex and two 16 channel spinal cord stimulation systems over cervical and lumbar regions. The brain-controlled spinal cord stimulation is used for training and rehabilitation to recover voluntary movements of the upper and lower limbs.
Multiple visits for implantation and rehabilitation sessions over the study duration
Duration - 5 years
Participants undergo periodic assessments to evaluate neurological recovery and functional improvements through various motor function tests and scales at baseline, 6 months, 1 year, and yearly up to 5 years post-implantation.
Assessments lasting 1 to 2 weeks at Baseline, 6 months, 1 year, and annually up to 5 years
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Henri Lorach, Andrea Galvez, Valeria Spagnolo...
https://pubmed.ncbi.nlm.nih.gov/37225984/S Puentes, T Kaido, T Hanakawa...
https://pubmed.ncbi.nlm.nih.gov/25453768/Clemens M Schirmer, Jay L Shils, Jeffrey E Arle...
https://pubmed.ncbi.nlm.nih.gov/21476796/Marc P Powell, Nikhil Verma, Erynn Sorensen...
https://pubmed.ncbi.nlm.nih.gov/36807682/Claudia Kathe, Michael A Skinnider, Thomas H Hutson...
https://pubmed.ncbi.nlm.nih.gov/36352232/Lazar I Jovanovic, Naaz Kapadia, Vera Zivanovic...
https://pubmed.ncbi.nlm.nih.gov/33741900/Kenji Kato, Masahiro Sawada, Yukio Nishimura
https://pubmed.ncbi.nlm.nih.gov/31619680/Sophie Wist, Julie Clivaz, Martin Sattelmayer
https://pubmed.ncbi.nlm.nih.gov/26969343/A Biasiucci, R Leeb, I Iturrate...
https://pubmed.ncbi.nlm.nih.gov/29925890/Alim Louis Benabid, Thomas Costecalde, Andrey Eliseyev...
https://pubmed.ncbi.nlm.nih.gov/31587955/Ecole Polytechnique Fédérale de Lausanne
Lead Sponsor